Enzyme Catalysis and Regulation
3-Nitropropionic Acid Is a Suicide Inhibitor of Mitochondrial Respiration That, upon Oxidation by Complex II, Forms a Covalent Adduct with a Catalytic Base Arginine in the Active Site of the Enzyme*

https://doi.org/10.1074/jbc.M511270200Get rights and content
Under a Creative Commons license
open access

We report three new structures of mitochondrial respiratory Complex II (succinate ubiquinone oxidoreductase, E.C. 1.3.5.1) at up to 2.1 Å resolution, with various inhibitors. The structures define the conformation of the bound inhibitors and suggest the residues involved in substrate binding and catalysis at the dicarboxylate site. In particular they support the role of Arg297 as a general base catalyst accepting a proton in the dehydrogenation of succinate. The dicarboxylate ligand in oxaloacetate-containing crystals appears to be the same as that reported for Shewanella flavocytochrome c treated with fumarate. The plant and fungal toxin 3-nitropropionic acid, an irreversible inactivator of succinate dehydrogenase, forms a covalent adduct with the side chain of Arg297. The modification eliminates a trypsin cleavage site in the flavoprotein, and tandem mass spectroscopic analysis of the new fragment shows the mass of Arg297 to be increased by 83 Da and to have the potential of losing 44 Da, consistent with decarboxylation, during fragmentation.

Cited by (0)

The atomic coordinates and structure factors (codes 2FBW, 1YQ3, and 1YQ4) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

*

This work was supported in part by National Institutes of Health R01 Grants GM62563 and DK44842 and NIA, National Institutes of Health Grant PO1 AG15885. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains supplemental materials (parts S1–S8).

1

Present address: Division of Bioorganic Chemistry and Molecular Pharmacology, Dept. of Internal Medicine, Washington University School of Medicine, Campus Box 8020, 660 South Euclid Ave., St. Louis, MO 63110.

2

Present address: Ecole Superieure de Biotechnologie de Strasbourg, UMR7100 CNRS, Boulevard Sebastien Brant, BP 10413, 67412 Illkirch, France.